Ken Griffin Masimo Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$104.79 - $133.77 $702,093 - $896,259	-6,700 Reduced 16.3%	34,400 $4.58 Million
Q2 2024 Aug 14, 2024	SELL	$115.24 - $144.91 $1.44 Million - $1.81 Million	-12,500 Reduced 23.32%	41,100 $5.18 Million
Q1 2024 May 15, 2024	SELL	$109.17 - $146.85 $2.35 Million - $3.16 Million	-21,500 Reduced 28.63%	53,600 $7.87 Million
Q4 2023 Feb 14, 2024	BUY	$76.73 - $120.62 $905,414 - $1.42 Million	11,800 Added 18.64%	75,100 $8.8 Million
Q3 2023 Nov 14, 2023	BUY	$84.17 - $161.17 $4.45 Million - $8.53 Million	52,900 Added 508.65%	63,300 $5.55 Million
Q2 2023 Aug 14, 2023	SELL	$155.24 - $196.47 $372,576 - $471,528	-2,400 Reduced 18.75%	10,400 $1.71 Million
Q1 2023 May 15, 2023	SELL	$146.03 - $184.54 $1.9 Million - $2.4 Million	-13,000 Reduced 50.39%	12,800 $2.36 Million
Q4 2022 Feb 14, 2023	BUY	$110.88 - $150.36 $2.44 Million - $3.31 Million	22,000 Added 578.95%	25,800 $3.82 Million
Q3 2022 Nov 14, 2022	SELL	$125.58 - $169.38 $1.82 Million - $2.46 Million	-14,500 Reduced 79.23%	3,800 $536,000

394

43M

310K

268K

Ticker MASI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 52,530,200
Market Cap $8.86B
Description
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.